Filter the latest scan's published facts — sector, size, yield, valuation — or rank them with a preset: cheapest, fastest growing, most profitable. Every view shows what is in the filings and prices; none ranks opportunity. The model behind the statuses showed no predictive power, and nothing here is a recommendation.
Scan of 2026-08-31 · 2,409 names scored · prices as of that date
Highest trailing growth versus sector peers, latest scan: sector percentiles on revenue TTM YoY, 3-year revenue CAGR, EPS growth and FCF growth, averaged. It describes the trailing record in the filings — past growth, which the backtest found predicts nothing about future returns.
Tested the unforgiving way: a composite ranking built from these same point-in-time filings (2017-01-31 to 2026-05-29) showed no measurable predictive power (mean IC 0.0168, t = 1.21), and its top quintile did not beat holding everything even before costs. Ranks like these describe today's record; they do not predict tomorrow's return.
160 names — page 3 of 4 · sector: Healthcare · Export CSV
| # | Ticker | Company | Sector | Growth composite | Revenue YoY | Revenue 3y CAGR | EPS growth YoY | Own 5y |
|---|---|---|---|---|---|---|---|---|
| 101 | WST | West Pharmaceutical Services, Inc. | Healthcare | 40.7 | 8.8% | 4.0% | 11.4% |
Never the absolute multiple alone. A P/E of 9 is a fact; whether it is low depends on what you hold it against.
The five-year window is the empirically privileged one. Cheap against its sector and cheap against its own history are different claims, and a stock can be one without being the other — which is the whole reason both columns are shown rather than blended into a single score.
| — |
| 102 | MD | Pediatrix Medical Group, Inc. | Healthcare | 40.6 | -0.5% | -1.1% | 63.2% | — |
| 103 | TNDM | Tandem Diabetes Care, Inc. | Healthcare | 40.2 | 2.6% | 9.1% | — | — |
| 104 | TDY | Teledyne Technologies Incorporated | Healthcare | 39.5 | 5.4% | 3.7% | 10.0% | — |
| 105 | TRMB | Trimble Inc. Common Stock | Healthcare | 38.7 | 3.1% | 0.3% | 60.9% | — |
| 106 | VLTO | Veralto Corporation | Healthcare | 38.4 | 4.3% | — | 8.8% | — |
| 107 | MDT | Medtronic plc | Healthcare | 37.0 | 6.3%FY | 4.8%FY | 2.9%FY | — |
| 108 | MSA | Mine Safety Incorporated | Healthcare | 36.9 | 4.9% | 4.7% | — | — |
| 109 | A | Agilent Technologies Inc. | Healthcare | 36.2 | 6.5% | 1.1% | 16.7% | — |
| 110 | BLCO | Bausch + Lomb Corporation | Healthcare | 35.3 | 6.5% | 10.1% | — | — |
| 111 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 34.7 | 7.3% | 5.3% | -6.4% | — |
| 112 | FEIM | Frequency Electronics, Inc. | Healthcare | 33.7 | -2.9% | 18.5% | -70.2% | — |
| 113 | CHE | Chemed Corporation | Healthcare | 33.7 | 1.1% | 5.1% | -3.9% | — |
| 114 | FLGT | Fulgent Genetics, Inc. Common Stock | Healthcare | 32.9 | 5.6% | 1.4% | — | — |
| 115 | AHCO | AdaptHealth Corp. Common Stock | Healthcare | 31.9 | 1.4% | 2.2% | -199.7% | — |
| 116 | GEHC | GE HealthCare Technologies Inc. Common Stock | Healthcare | 31.8 | 5.1% | — | -14.6% | — |
| 117 | COHU | Cohu Inc | Healthcare | 31.7 | 22.2% | -13.6% | — | — |
| 118 | ITRI | Itron Inc | Healthcare | 31.0 | -3.9% | 6.8% | 9.2% | — |
| 119 | ONTO | Onto Innovation Inc. | Healthcare | 30.5 | -0.6% | 4.7% | -33.5%FY | — |
| 120 | EW | Edwards Lifesciences Corp | Healthcare | 30.2 | 10.9% | 3.7% | -73.2% | — |
| 121 | COO | The Cooper Companies, Inc. Common Stock | Healthcare | 30.1 | 4.6% | 6.4% | -40.7% | — |
| 122 | TMO | Thermo Fisher Scientific, Inc. | Healthcare | 30.0 | 4.6% | 1.3% | — | — |
| 123 | ALGN | Align Technology Inc | Healthcare | 29.5 | 3.3% | 3.1% | -0.4% | — |
| 124 | ANGO | AngioDynamics, Inc. | Healthcare | 29.4 | 7.3% | -2.5% | — | — |
| 125 | HAE | Haemonetics Corporation | Healthcare | 29.1 | 0.0%FY | 5.2%FY | 10.5% | — |
| 126 | LHX | L3Harris Technologies, Inc. | Healthcare | 28.8 | -0.2%FY* | 5.8%FY* | 2.1% | — |
| 127 | BLFS | BioLife Solutions Inc. | Healthcare | 28.8 | 8.8% | -14.4% | — | — |
| 128 | RVTY | Revvity, Inc. | Healthcare | 28.2 | 3.7% | 0.8% | -11.7% | — |
| 129 | BVS | Bioventus Inc. Class A Common Stock | Healthcare | 27.6 | 2.2% | 4.1% | — | — |
| 130 | OPCH | Option Care Health, Inc. Common Stock | Healthcare | 27.0 | 0.3% | 8.0% | 1.3% | — |
| 131 | BIO | Bio-Rad Laboratories, Inc.Class A | Healthcare | 26.8 | 0.7%FY | -2.7%FY | -46.6% | — |
| 132 | ACHC | Acadia Healthcare Company, Inc. | Healthcare | 26.7 | 4.4% | 6.7% | -891.3% | — |
| 133 | INGN | Inogen Inc | Healthcare | 26.0 | 3.6% | 1.3% | — | — |
| 134 | MLAB | Mesa Laboratories Inc | Healthcare | 25.6 | 2.8%FY | 4.3%FY | — | — |
| 135 | SGHT | Sight Sciences, Inc. Common Stock | Healthcare | 25.1 | 4.3% | -0.8% | — | — |
| 136 | KODK | EASTMAN KODAK COMPANY | Healthcare | 24.6 | 4.8% | -2.3% | — | — |
| 137 | LH | Labcorp Holdings Inc. | Healthcare | 24.4 | 4.9% | -1.6% | — | — |
| 138 | VNT | Vontier Corporation | Healthcare | 22.9 | 1.4% | -1.2% | — | — |
| 139 | SRTA | Strata Critical Medical, Inc. Class A Common Stock | Healthcare | 22.6 | -10.1% | 6.3% | — | — |
| 140 | ARDT | Ardent Health, Inc. | Healthcare | 22.2 | 3.7% | — | -47.4% | — |
| 141 | DHR | Danaher Corporation | Healthcare | 21.9 | 3.2% | -6.5% | 9.3% | — |
| 142 | TDOC | Teladoc Health, Inc. | Healthcare | 21.6 | -1.1% | -0.2% | — | — |
| 143 | MASS | 908 Devices Inc. Common Stock | Healthcare | 21.3 | -11.8% | 5.6% | — | — |
| 144 | TXG | 10x Genomics, Inc. Class A Common Stock | Healthcare | 20.9 | -0.9% | 4.0% | — | — |
| 145 | ILMN | Illumina Inc | Healthcare | 19.6 | 2.5% | -0.5% | -30.8% | — |
| 146 | BRKR | Bruker Corporation | Healthcare | 18.3 | 0.5% | 8.4% | -114.5% | — |
| 147 | BAX | Baxter International Inc. | Healthcare | 17.8 | 4.0% | -9.3% | — | — |
| 148 | IART | Integra LifeSciences Holdings | Healthcare | 14.8 | 1.4% | 2.1% | — | — |
| 149 | MMM | 3M Company | Healthcare | 13.6 | 1.7% | -8.9% | -28.2% | — |
| 150 | ANIK | Anika Therapeutics Inc | Healthcare | 12.1 | 1.5% | -10.5% | — | — |
"Growth composite" is a 0–100 position among valid sector peers — the mean of the component metrics' sector percentiles. "—" means the scan published no figure, deliberately. "n/a — masked" means the metric is misleading in that name's sector (a REIT's GAAP P/E, a bank's FCF yield) — hover for the reason, which comes from the same sector-validity rules the composite itself respects. An FY tag marks a trailing-year figure built from an annual filing; hover for what that means.
